Studies showed that microRNAs (miRNAs) encapsulated into liposome-protamine-hyaluronic acid nanoparticles could regulate CD47 expression levels, and results from animal models of solid tumors suggested that they could represent potential cancer strategies [72, 73]. This evidence concerns the gene CD47 and cancer.